A comprehensive review published in Frontiers in Endocrinology (2024) further confirms that GLP-1 drugs reshape gastrointestinal physiology and metabolic regulation at multiple levels, affecting far more than just appetite
Well stay with you every step of the way, offering regular in-person check-ups to track your progress and adjust dosages if needed
Theres also growing research that they may help treat heart disease, sleep apnea, kidney disease, substance use disorder and other conditions
If side effects are severe or persistent beyond the first few weeks, your GP or diabetes specialist may suggest: Temporary dose reduction Anti-emetic medication for nausea Review of concomitant diabetes medications to reduce hypoglycaemia risk Alternative GLP-1 receptor agonist formulations if oral semaglutide remains poorly tolerated According to NICE guidelines (NG28) , treatment decisions should be individualised based on efficacy, tolerability, patient preference, and cost-effectiveness
writingoriginal draft preparation, L.D